SB-AS02B adjuvant
Term · Oncology and biomedicine · MLC-T-ONC-016655
A proprietary oil-in-water emulsion specifically designed for combining protein preparations used in vaccines. SB-AS02B adjuvant contains monophosphoryl lipid A and QS21, a saponin extracted from the South American tree Quillaja saponaria Molina. This agent may be used for formulating cancer-specific vaccine preparations such as those containing MAGE-3 melanoma protein.
| Identifier | MLC-T-ONC-016655 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | SB AS02B |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-016655",
"term": "SB-AS02B adjuvant",
"field": "Oncology and biomedicine",
"definition": "A proprietary oil-in-water emulsion specifically designed for combining protein preparations used in vaccines. SB-AS02B adjuvant contains monophosphoryl lipid A and QS21, a saponin extracted from the South American tree Quillaja saponaria Molina. This agent may be used for formulating cancer-specific vaccine preparations such as those containing MAGE-3 melanoma protein.",
"abbreviation": "SB AS02B",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/sb-as02b-adjuvant/"
}
Record 14,706 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.